957535-53-4 Usage
Uses
Used in Pharmaceutical Industry:
(2R,3R,4R,5R)-5-((benzoyloxy)Methyl)-3-Methyl-2-(5-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate is used as a pharmaceutical compound for its potential therapeutic properties. Its complex structure and functional groups may contribute to the development of new drugs with specific targets and mechanisms of action.
Used in Organic Synthesis:
(2R,3R,4R,5R)-5-((benzoyloxy)Methyl)-3-Methyl-2-(5-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate is used as an intermediate in organic synthesis for the production of other complex organic molecules. Its unique structure and functional groups can be utilized in the synthesis of various compounds with potential applications in different industries.
Used in Material Science:
(2R,3R,4R,5R)-5-((benzoyloxy)Methyl)-3-Methyl-2-(5-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)tetrahydrofuran-3,4-diyl dibenzoate is used in material science for the development of new materials with specific properties. Its unique structure and functional groups can contribute to the creation of materials with potential applications in various fields, such as electronics, coatings, and adhesives.
Check Digit Verification of cas no
The CAS Registry Mumber 957535-53-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,7,5,3 and 5 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 957535-53:
(8*9)+(7*5)+(6*7)+(5*5)+(4*3)+(3*5)+(2*5)+(1*3)=214
214 % 10 = 4
So 957535-53-4 is a valid CAS Registry Number.
957535-53-4Relevant academic research and scientific papers
SUBSTITUTED NUCLEOTIDE ANALOGS
-
Page/Page column 111, (2012/04/04)
Disclosed herein are phosphorothioate nucleotide analogs, methods of synthesizing phosphorothioate nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with the phosphorothioate
2′-C-alkylribonucleosides: Design, synthesis, and conformation
Harry-O'kuru, Rogers E.,Kryjak, Emily A.,Wolfe, Michael S.
, p. 1457 - 1460 (2007/10/03)
Certain 2′-C-alkylribonucleotides have been designed as potential mechanism-based inactivators of ribonucleotide reductases. A short, flexible route toward the corresponding nucleosides and NMR evidence concerning their preferred solution conformations are discussed. Copyright
